Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Short Interest Down 14.2% in December

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOFGet Rating) saw a significant decrease in short interest during the month of December. As of December 30th, there was short interest totalling 925,500 shares, a decrease of 14.2% from the December 15th total of 1,078,200 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 9,255.0 days.

Kyowa Kirin Price Performance

OTCMKTS:KYKOF opened at $22.28 on Friday. The stock has a 50-day simple moving average of $22.49 and a two-hundred day simple moving average of $22.73. Kyowa Kirin has a 52-week low of $21.22 and a 52-week high of $23.85.

Kyowa Kirin Company Profile

(Get Rating)

Kyowa Kirin Co, Ltd. manufactures and markets pharmaceuticals that focuses on the therapeutic areas of oncology, nephrology, central nervous system, and immunology worldwide. Its products include ABSTRAL, a sublingual formulation of fentanyl used for the management of episodes of breakthrough pain experienced by cancer patients; ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.

See Also

Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with's FREE daily email newsletter.